Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02715427
Other study ID # 2015-A01806-43
Secondary ID
Status Recruiting
Phase N/A
First received March 11, 2016
Last updated April 1, 2016
Start date April 2016

Study information

Verified date April 2016
Source University Hospital, Angers
Contact Emilie Lermite, MD-PhD
Phone 02 41 35 36 18
Email EmLermite@chu-angers.fr
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

Enhanced rehabilitation programs are based on new therapies and treatment combinations to reduce the length of hospitalization, duration of postoperative convalescence, morbidity, but also the overall cost of care. The operating stress and hypercatabolic conditions surrounding the surgery are sources of complications. In this enhanced rehabilitation approach, the principle is to fight through a series of actions against this surgical stress. Several North American studies, Chinese, Scandinavian or Batavian have shown the feasibility and the interest of enhanced perioperative rehabilitation in liver surgery. Nevertheless, there is not until now French data concerning the assessment of enhanced rehabilitation in liver surgery. The main objective of the study is to compare the effectiveness of the implementation of a multimodal management program after liver surgery in a French university center compared to conventional care. Secondary objectives of the study are to compare an enhanced rehabilitation program in liver surgery versus conventional treatment in terms of morbidity and mortality in the immediate postoperative period and until day 90, length of hospital stay, blood loss and the delay to bowel mobility recovery. Compliance to the program in both groups will also be evaluated.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Patient to be operated on for hepatectomy in Universitary Hospital of Angers

- No emergency surgery

- No bilio-digestive anastomosis

- Body Mass Index between 18 and 40 kg/m2

- Preoperative morbidity status graded with the American Society of Anesthesiologists (ASA) between I to III

- Affiliated to the national health insurance

Exclusion Criteria:

- Pregnant woman

- Patient who doesn't speack french

- Colorectal surgery combined

- Postoperative stay predictable in critical care unit

- Patient under law protection

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
Conventional care

Enhanced recovery


Locations

Country Name City State
France CHU Angers Angers Maine et Loire

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Day number to functional recovery The evaluation of time to functional recovery is scored once a day. A patient is fully functionally recovered when all of the following criteria are satisfied:
adequate pain control with oral analgesia: Post-operative pain is rated by the numeric rating scale. Nurses ask patients the intensity of their current pain on a scale of 0 (no pain) to 10 (worst possible pain). To satisfy this criterion, patient must rate their pain between 0 to 3 with only oral analgesics.
restoration of mobility to an independent level We decided to use the Groningen Activity Restriction Scale for rated the difference between preoperative and postoperative mobility level. To satisfy this criterion, patient must have the same score in postoperative.
absence of intravenous fluid administration for at least 24 hours.
ability to eat solid foods well tolerated for at least 24 hours to satisfy this criterion.
normal or decreasing serum bilirubin level and international normalised ratio.
90 days Yes
See also
  Status Clinical Trial Phase
Completed NCT04092608 - Restrictive vs Goal Directed Fluid Therapy During Hepatobiliary Surgery N/A
Completed NCT02993640 - Optimization of Hepatic Hemodynamics During Liver Surgery Early Phase 1
Completed NCT05116735 - Biliary Fistula and Late Recurrence of Liver Hydatid Cyst: Role of Cysto-biliary Communication N/A
Recruiting NCT03686137 - Institut Paoli Calmettes Hepatic Surgery Database
Recruiting NCT05594641 - Lactate Clearance After RIPC in Liver Resection N/A
Active, not recruiting NCT03270917 - ORANGE SEGMENTS: Open Versus Laparoscopic Parenchymal Preserving Postero-Superior Liver Segment Resection N/A
Completed NCT03793933 - ACS-NSQIP Calculator for Liver Surgery
Completed NCT01523353 - Prehabilitation in Liver Surgery Phase 1
Completed NCT00918619 - Efficacy and Safety of Sangustop® as Haemostatic Agent Versus a Carrier-Bound Fibrin Sealant During Liver Resection Phase 4
Completed NCT02050841 - Octaplas Pediatric Plasma Replacement Trial Phase 4
Recruiting NCT01267786 - The Effect of Volatile Anesthetics Sevoflurane and Desflurane on Liver, Renal and Cardiovascular Systems During Liver Surgery Phase 4
Completed NCT04668391 - Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament for Analgesia After Open Liver Surgery N/A